IRIS
ALTAVILLA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.064
EU - Europa 5.681
AS - Asia 4.055
SA - Sud America 1.612
AF - Africa 104
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.534
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.945
SG - Singapore 1.781
BR - Brasile 1.458
IE - Irlanda 1.312
SE - Svezia 1.237
CN - Cina 1.158
IT - Italia 788
HK - Hong Kong 518
DE - Germania 490
UA - Ucraina 479
GB - Regno Unito 300
FI - Finlandia 263
RU - Federazione Russa 229
PL - Polonia 190
VN - Vietnam 175
FR - Francia 120
IN - India 90
BE - Belgio 64
TR - Turchia 54
AR - Argentina 47
CA - Canada 44
BD - Bangladesh 40
MX - Messico 40
ZA - Sudafrica 33
AT - Austria 32
EC - Ecuador 32
NL - Olanda 31
ES - Italia 30
ID - Indonesia 30
IQ - Iraq 30
UZ - Uzbekistan 24
CZ - Repubblica Ceca 23
MA - Marocco 22
CO - Colombia 21
JP - Giappone 18
VE - Venezuela 17
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
IR - Iran 12
AL - Albania 11
LT - Lituania 11
BO - Bolivia 10
CH - Svizzera 10
CI - Costa d'Avorio 10
TN - Tunisia 10
JO - Giordania 9
KE - Kenya 9
KG - Kirghizistan 9
PK - Pakistan 9
AU - Australia 8
GR - Grecia 8
KZ - Kazakistan 8
PY - Paraguay 8
DO - Repubblica Dominicana 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
OM - Oman 7
CL - Cile 6
PE - Perù 6
RS - Serbia 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GE - Georgia 5
NI - Nicaragua 5
NO - Norvegia 5
NP - Nepal 5
PA - Panama 5
RO - Romania 5
SA - Arabia Saudita 5
UY - Uruguay 5
BY - Bielorussia 4
HN - Honduras 4
KW - Kuwait 4
LV - Lettonia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
HR - Croazia 3
KR - Corea 3
LB - Libano 3
NZ - Nuova Zelanda 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BW - Botswana 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
KH - Cambogia 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
TW - Taiwan 2
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 19.516
Salva come PNG Salva come JPEG
Città #
Dublin 1.312
Chandler 1.006
Jacksonville 941
Dallas 918
Ashburn 873
Singapore 829
Nyköping 691
Hong Kong 513
Beijing 478
Dearborn 251
Ann Arbor 244
Los Angeles 234
Princeton 220
Medford 201
Cambridge 199
Warsaw 182
Messina 160
New York 159
The Dalles 154
Des Moines 152
Boardman 129
Munich 121
Lancaster 110
São Paulo 107
Buffalo 90
Jinan 78
Tianjin 67
Woodbridge 67
Brussels 61
Ho Chi Minh City 58
Shenyang 52
Redondo Beach 51
Rio de Janeiro 50
Turku 50
Wilmington 49
San Mateo 45
Moscow 44
Houston 36
Belo Horizonte 35
Nanjing 35
Hanoi 33
Frankfurt am Main 32
Santa Clara 30
Hyderabad 29
Rome 29
Catania 28
Hebei 27
Zhengzhou 27
Brasília 26
Brooklyn 26
Pune 26
Vienna 26
San Francisco 24
Council Bluffs 23
Seattle 23
Tashkent 23
Chicago 22
Jakarta 22
London 22
Milan 22
Montreal 22
Curitiba 21
Washington 21
Haikou 20
Nanchang 20
Nuremberg 20
Porto Alegre 20
Atlanta 19
Düsseldorf 19
Helsinki 19
Denver 18
Ningbo 18
Tokyo 18
Dong Ket 17
Johannesburg 17
Norwalk 17
Boston 16
Ankara 15
Bremen 15
Campinas 15
Istanbul 15
Phoenix 15
Ribeirão Preto 15
Scarsdale 15
Stockholm 15
Brno 14
Salvador 14
Sorocaba 14
Taizhou 14
Baghdad 13
Changsha 13
Hangzhou 13
Jiaxing 13
Redwood City 13
Baku 12
Guangzhou 12
Guayaquil 12
Amsterdam 11
Guarulhos 11
Lauterbourg 11
Totale 12.204
Salva come PNG Salva come JPEG
Nome #
PARAGANGLIOMA MALIGNO DEL CORPO CAROTIDEO.Rilievi Clinici, Morfologici, Istochimici E Ultrastrutturali Su Un Caso. 395
Su di un caso di pseudomyxoma peritonei con diffusione spontanea alla pleura. 163
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. 162
Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy 160
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 158
Annual increase in the frequency of papillary thyroid carcinoma as diagnosed by fine-needle aspiration at a cytology unit in Sicily. 158
Mechanical dispersion and cardiotoxicity in patients who underwent chemotherapy for breast cancer: an echocardiographic study 158
Bone and lymph node metastases from occult mammary carcinoma: a case report of carcinoma of unknown primary (CUP) Syndrome 155
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 146
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 146
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 144
Analysis of multilayer strain and myocardial work in patients undergoing chemotherapy treatment: a 12 months follow-up 143
Liver dysfunction in hcv infected patients with CD20-Positive B-Cell Lymphoma undergoing rituximab combination chemotherapy 140
Should the Use of Surveillance Imaging in Diffuse Large B-Cell Lymphoma Be Discontinued? 139
[Serum levels of copper and zinc in patients with lung cancer] 138
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 136
Applications of genomics in NSCLC 134
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy 133
An acute-leukaemia-like picture due to breast carcinoma cells. 132
EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients. 132
Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer 132
Myocardial damage pattern in women with breast cancer who underwent chemotherapy: strain polar maps analysis 132
A study of endometrial adenocarcinoma treated with tamoxifen by scanning and transmission electron microscopy. 129
Liquid biopsy for lung cancer early detection 128
A randomized factorial trial of sequential doxrubicina and CMF vs CMF and chemoterapy alone vs chemoterapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer 127
Alectinib: A selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer 127
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 126
Left atrial function in patients undergoing chemotherapy: additional value of 2D longitudinal strain 126
[(186)Re]HEDP in the palliation of painful bone metastases from cancers otherthan prostate and breast. 125
Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome. 125
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 125
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 124
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 123
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 123
The treatment of peritoneal carcinomatosis in elderly patients. 123
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 123
Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck 122
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 122
Early assessment of chemotherapy-related cardiovascular toxicity in patients with breast cancer 122
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 120
Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. 120
A PHASE III RANDOMIZED TRIAL COMPARING THREE PLATINUM-BASED DOUBLETS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): IMPACT OF PS=2 VS 0 OR 1 AND AGE ³70 VS <70 ON CHEMOTHERAPY OUTCOME 119
A novel HPLC method for the determination of mitoxantrone in pharmaceutical formulations. 119
Studio anatomo-clinico di due casi di sarcoma sinoviale monofasico del ginocchio 118
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 118
Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade. 117
Razionale e tecniche della chirurgia citoriduttiva e della chemioipertermia peritoneale. 116
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer. 116
Endocrine toxicity of immune checkpoint inhibitors (anti-PD-1/PD-L1) in advanced cancer 116
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 114
Psycho-Neuro-Endocrine-Immune System (PNEI) Involvement as Prognostic Marker in Breast Cancer Patients at 10 Years of Follow Up 114
A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin 113
Analytical profile and release of lonidamine from pharmaceutical formulation 113
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 113
Targeted drugs in small-cell lung cancer 111
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 110
90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST 110
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 109
Sternal metastasis as initial presentation of a unknown rectal cancer 108
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 108
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 107
Clodronate and radiotherapy for the treatment of osteolysis caused by metastasis of breast carcinoma and non-small cell lung carcinoma. A retrospective study 105
Trattamento palliativo dei tumori del retto-sigma mediante elettrocoagulazione endoscopica.” 105
SUBCUTANEOUS LOW-DOSE ALEMTUZUMAB AS FIRST LINE THERAPY FOR ELDERLY CLL PATIENTS WITH DELETION OF 17p 104
A PHASE II STUDY (21 day regimen) OF GEMCITABINE (Gem) AND CISPLATIN ( Cis) IN ADVANCED/METASTATIC TRANSITIONAL CELL CARCINOMA (TTC) OF BLADDER 104
La farmacogenomica nei tumori del polmone 104
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 104
Thyroid function, autoimmunity and nodules in hematological malignancies 104
Unusual relapse of hepatocellular carcinoma 104
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 104
Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases 103
Peritoneal carcinomatosis of colorectal origin. 103
Retrospective analiysis of P-STAT6 expression as predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate 102
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 101
Transpersonal Therapy Combined with Best Supportive Care In Hospice Improve Patient’s Quality of Life and Quality Of Death 100
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 100
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 99
INFLUENCE OF CYP2C9 POLYMORPHISM IN LUNG CANCER SUSCEPTIBILITY 97
Relapsed or refractory extranodal DLBCL treated with lenalidomide: A single center study 97
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study 96
Treatment of advanced and/or metastatic epidermoid carcinoma of the head and neck: an effective combination chemotherapy with bleomycin, methotrexate and ftorafur. 96
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 96
Gemcitabine combined with Oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma 96
Phase II study paclitaxel (PTX) and cisplatin (Cis) in advanced and recurrent head&neck cancer 95
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery 95
First Line Chemotherapy with Oral Vinorelbine (oV) in Elderly Hormone-Refractory Prostate Cancer (HRPC) Patients (pts 94
Behavior of serum sialic acid levels at various stages of neoplastic disease 94
Use of bisphosphonates in oncology 94
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer. 93
The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB) 93
PIK3CA mutations in breast cancer: a potential marker 92
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 92
ZD 1839 IRESSA IN HEAVELY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) ASSESSMENT OF TOLERABILITY AND THE CLINICAL BENEFIT 91
Serum levels of copper and zinc in patients with lung cancer 91
Temozolomide-induced shrinkage of a pituitary carcinoma. 91
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors. 90
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 90
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 90
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 90
Microvessels density evaluation in human meningiomas: an immunohistochemical investigation by the specific marker for neoangiogenesis CD105 (Endoglin). 88
Totale 11.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.894
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021784 0 0 0 0 0 170 48 148 64 169 118 67
2021/20221.555 10 224 45 40 59 20 84 61 31 244 269 468
2022/20233.927 312 372 174 289 306 401 57 236 1.613 22 96 49
2023/2024998 76 128 66 115 74 261 23 45 3 80 26 101
2024/20254.341 57 38 75 254 222 135 75 1.028 1.162 250 339 706
2025/20264.079 621 668 1.013 695 977 105 0 0 0 0 0 0
Totale 19.823